Peter Reikes

Peter Reikes

Direttore/Membro del Consiglio presso IONIS PHARMACEUTICALS, INC.
65 anni
Health Technology
Finance
Consumer Services

Profilo

Peter N.
Reikes
is currently Director at Heart & Soul Foundation and Director at Ionis Pharmaceuticals, Inc. starting in 2026.
Formerly, Mr. Reikes was Vice Chairman & Head-Healthcare Investment Banking at Cowen & Co. LLC from 2010, Vice Chairman-Healthcare Investment Banking at Stifel, Nicolaus & Co., Inc. in 2010, Director at Alkermes, Inc., Cephalon LLC, Repligen Corp., SICOR, Inc., Genzyme Corp., Concord Biosciences LLC, and Biocompatibles UK Ltd. Mr. Reikes was Independent Director at Ionis Pharmaceuticals, Inc. from 2018 to 2021 and MD & Head-Healthcare Investment Banking at PaineWebber, Inc. from 1985 to 1998.
Education includes undergraduate studies at the University of California, Los Angeles and an MBA from The Wharton School of the University of Pennsylvania.

Posizioni attive di Peter Reikes

SocietàPosizioneInizio
IONIS PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 04/06/2026
Heart & Soul Foundation
Direttore/Membro del Consiglio -

Precedenti posizioni note di Peter Reikes

SocietàPosizioneFine
IONIS PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 21/11/2021
Corporate Officer/Principal 26/10/2010
Corporate Officer/Principal 30/09/2010
Corporate Officer/Principal 31/12/1998
Direttore/Membro del Consiglio -
Vedi nel dettaglio l'esperienza di Peter Reikes

Formazione di Peter Reikes

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

99

Relazioni di 1° grado

14

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private14

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Finance

Finance

Consumer Services

Commercial Services

Health Technology

Consumer Services

Heart & Soul Foundation

  1. Mercati
  2. Insiders
  3. Peter Reikes
40% di sconto: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA